vs
Side-by-side financial comparison of Fulgent Genetics, Inc. (FLGT) and MERCANTILE BANK CORP (MBWM). Click either name above to swap in a different company.
Fulgent Genetics, Inc. is the larger business by last-quarter revenue ($71.1M vs $67.6M, roughly 1.1× MERCANTILE BANK CORP). Over the past eight quarters, MERCANTILE BANK CORP's revenue compounded faster (9.1% CAGR vs 0.1%).
Fulgent Genetics, Inc. is a molecular diagnostics technology firm that develops and offers genetic testing services including carrier screening, oncology testing, infectious disease detection, and hereditary condition analysis, serving clinical providers, pharma firms, research institutions and public health groups primarily in North America.
Tamilnad Mercantile Bank Limited (TMB) is an Indian bank headquartered at Thoothukudi, Tamil Nadu. TMB was founded in 1921 as the Nadar Bank, but changed its name to Tamilnad Mercantile Bank in November 1962 to widen its appeal beyond the Nadar community. The bank currently has 600 full branches throughout India, 12 regional offices and two link offices, two central processing centres, one service branch, four currency chests, 48 eLobby centres, 262 cash recycler machines and 1151 automated ...
FLGT vs MBWM — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $71.1M | $67.6M |
| Net Profit | — | $22.7M |
| Gross Margin | 30.2% | — |
| Operating Margin | 21.1% | — |
| Net Margin | — | 33.6% |
| Revenue YoY | -3.2% | — |
| Net Profit YoY | — | 16.1% |
| EPS (diluted) | $0.04 | $1.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $71.1M | $67.6M | ||
| Q4 25 | $83.3M | $62.1M | ||
| Q3 25 | $84.1M | $62.4M | ||
| Q2 25 | $81.8M | $60.9M | ||
| Q1 25 | $73.5M | $57.3M | ||
| Q4 24 | $76.2M | $58.5M | ||
| Q3 24 | $71.7M | $58.0M | ||
| Q2 24 | $71.0M | $56.8M |
| Q1 26 | — | $22.7M | ||
| Q4 25 | $-23.4M | $22.8M | ||
| Q3 25 | $-6.6M | $23.8M | ||
| Q2 25 | $-19.0M | $22.6M | ||
| Q1 25 | $-11.5M | $19.5M | ||
| Q4 24 | $-5.9M | $19.6M | ||
| Q3 24 | $-14.6M | $19.6M | ||
| Q2 24 | $-8.7M | $18.8M |
| Q1 26 | 30.2% | — | ||
| Q4 25 | 39.1% | — | ||
| Q3 25 | 42.2% | — | ||
| Q2 25 | 42.1% | — | ||
| Q1 25 | 38.6% | — | ||
| Q4 24 | 41.8% | — | ||
| Q3 24 | 37.3% | — | ||
| Q2 24 | 37.3% | — |
| Q1 26 | 21.1% | — | ||
| Q4 25 | -43.5% | 42.0% | ||
| Q3 25 | -18.3% | 44.0% | ||
| Q2 25 | -24.1% | 42.6% | ||
| Q1 25 | -26.9% | 42.0% | ||
| Q4 24 | -21.2% | 39.7% | ||
| Q3 24 | -23.8% | 42.4% | ||
| Q2 24 | -26.6% | 41.4% |
| Q1 26 | — | 33.6% | ||
| Q4 25 | -28.1% | 36.8% | ||
| Q3 25 | -7.9% | 38.1% | ||
| Q2 25 | -23.2% | 37.1% | ||
| Q1 25 | -15.7% | 34.1% | ||
| Q4 24 | -7.7% | 33.5% | ||
| Q3 24 | -20.4% | 33.8% | ||
| Q2 24 | -12.3% | 33.1% |
| Q1 26 | $0.04 | $1.32 | ||
| Q4 25 | — | $1.41 | ||
| Q3 25 | — | $1.46 | ||
| Q2 25 | — | $1.39 | ||
| Q1 25 | — | $1.21 | ||
| Q4 24 | — | $1.20 | ||
| Q3 24 | — | $1.22 | ||
| Q2 24 | — | $1.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $23.4M | — |
| Total DebtLower is stronger | — | $1.5M |
| Stockholders' EquityBook value | — | $736.9M |
| Total Assets | $1.2B | $6.9B |
| Debt / EquityLower = less leverage | — | 0.00× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $23.4M | — | ||
| Q4 25 | $50.2M | — | ||
| Q3 25 | $117.6M | — | ||
| Q2 25 | $87.9M | — | ||
| Q1 25 | $67.3M | — | ||
| Q4 24 | $55.1M | — | ||
| Q3 24 | $58.0M | — | ||
| Q2 24 | $65.1M | — |
| Q1 26 | — | $1.5M | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | $736.9M | ||
| Q4 25 | $1.1B | $724.9M | ||
| Q3 25 | $1.1B | $657.6M | ||
| Q2 25 | $1.1B | $631.5M | ||
| Q1 25 | $1.1B | $608.3M | ||
| Q4 24 | $1.1B | $584.5M | ||
| Q3 24 | $1.1B | $583.3M | ||
| Q2 24 | $1.1B | $551.2M |
| Q1 26 | $1.2B | $6.9B | ||
| Q4 25 | $1.2B | $6.8B | ||
| Q3 25 | $1.2B | $6.3B | ||
| Q2 25 | $1.2B | $6.2B | ||
| Q1 25 | $1.2B | $6.1B | ||
| Q4 24 | $1.2B | $6.1B | ||
| Q3 24 | $1.2B | $5.9B | ||
| Q2 24 | $1.2B | $5.6B |
| Q1 26 | — | 0.00× | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FLGT
Segment breakdown not available.
MBWM
| Net Interest Income | $55.9M | 83% |
| Noninterest Income | $11.7M | 17% |
